Stoic VC
Venture capitalSydney · Pre-Seed–Series A · 5 people tracked
Find your way into Stoic VC
376 people in our graph share verified history with the Stoic VC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Stoic backs scientists and engineers commercialising research from leading Australian universities, aiming to turn breakthrough science into commercially viable, high-velocity technologies. It focuses on three areas: human health (products advancing standard of care), advanced computing (next-generation processing and computational systems), and the physical world (addressing environmental challenges). The firm typically enters after a startup has demonstrated proof of concept of its research, writing first cheques from roughly A$100K to A$1M. Partnered with Uniseed since 2019, it offers founders direct access to investors, operators and academics, drawing on decades of commercialisation experience and connections across ten of Australia's top research institutions.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website
What they invest in
from 17 of 25 portfolio companiesHealthtech ×11Medical Devices ×11Biotech ×8Digital Health ×5AI & Machine Learning ×3Hardware ×3IoT ×3Deep Tech ×2
HQs:Australia×11United States×2
Investments · 25 tracked
founders shown can be your intro path
Kinoxis Therapeutics develops novel therapeutics targeting inflammatory signaling pathways in the nervous system to address unmet needs in CNS disorders, with initial focus on treatments for agitation and pain.
BiotechDigital HealthHealthtechMedical DevicesMelbourne, AU
Hugh Alsop(Chief Executive Officer, Co-Founder)inMichael Bowen(Chief Scientific Officer, Co-Founder)in
Co-investorsUniSeed Pty Ltd.
Axelia Oncology is a biopharmaceutical company developing AXA-042, a selective immunological agent designed to activate innate immune responses against checkpoint-insensitive solid tumors.
BiotechHealthtechMedical DevicesMelbourne, AU
David Jackson(Founder (Laboratory research origin))Grant Mchlachlan(Chief Executive Officer)
BioScout provides autonomous, solar-powered air sampling devices that detect and identify airborne fungal spores, combining live spore counts with weather data to give growers, agronomists, and agrochemical distributors disease-risk intelligence for fungicide spray timing.
AgTechAI & Machine LearningDeep TechHardwareIoT
Lewis Collins(CEO)in
Co-investorsArtesianUniSeed Pty Ltd.
Cardihab provides a digital cardiac rehabilitation platform that uses smartphone apps and web portals to enable clinicians to deliver remote and flexible rehabilitation services to patients with heart disease.
Digital HealthHealthtechMedical DevicesQueensland, AU
Co-investorsUniSeed Pty Ltd.
Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis.
BiotechHealthtechMedical Devices
Co-investorsUniSeed Pty Ltd.
ENA Respiratory develops and brings respiratory treatments to market across the US and other regions.
BiotechHealthtechMedical DevicesMelbourne, AU
Christophe Demaison(CEO)in
Co-investorsBrandon BioCatalystUniSeed Pty Ltd.
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)in
Co-investorsO2h VenturesWellcome TrustWren CapitalCambridge Angels groupEMV CapitalMartlet Capital+1 more
Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic.
BiotechHealthtechMedical Devices
Benjamin Thierry(Scientific Advisor/Founder)inStewart Bartlett(CEO)inAnil Shetty(CMO)in
Co-investorsArtesianSouth Australian Venture Capital FundBooster Innovation FundMatūUniSeed Pty Ltd.
Lenexa Medical provides fabric-based sensor technology and AI software embedded in hospital mattresses to continuously monitor patient positioning and pressure, enabling healthcare staff to prevent pressure injuries through real-time data and targeted interventions.
AI & Machine LearningDigital HealthHealthtechMedical DevicesMelbourne, AU
Ajit Ravindran(CEO)inWill Yang(CSO)in
Co-investorsMedTech Actuator
Morse Micro designs Wi-Fi HaLow (IEEE 802.11ah) system-on-chip semiconductors that provide long-range, low-power sub-1 GHz wireless connectivity for IoT devices such as security cameras, dongles, and access points.
HardwareIoTSemiconductorsSydney, AU
Andrew Terry(Co-founder & CTO)inMichael De Nil(Co-founder & CEO)inJoe Bedewi(Chief Financial Officer)in
Co-investorsMain Sequence VenturesBlackbird VenturesRight Click CapitalSpringCapital InvestmentVirescent VenturesStartmate+1 more
NatureHelm is a biodiversity intelligence platform that aggregates remote sensing and ground-based species data to help corporations, financial institutions, and primary producers assess and report nature-related risks, impacts, and dependencies.
Climate TechData & InfrastructureSaaS
Dr Debbie Saunders(Co-founder, Conservation Ecologist & CEO)inPhil Keaton(Co-founder, Innovative Technology & CPO)inAlexandra Kmita(CMO)
Neurode develops a wearable neurostimulation headband paired with a companion app that provides personalized insights and recommendations from psychologists, neuroscientists, and engineers.
AI & Machine LearningDigital HealthHardwareMedical DevicesMental Health
Damian(CTO)
Co-investorsPsyMed Ventures
An online gambling platform licensed under Curacao eGaming, offering video slots, live dealer tables, progressive jackpots, and specialty games from studios such as NetEnt, Microgaming, and Pragmatic Play.
Co-investorsBrandon BioCatalystBrandon Capital Partners
PERKii is a beverage company that produces probiotic drinks designed to support gut health and immunity.
ConsumerFoodTechHealthtechWellness & FitnessBrisbane, AU
Co-investorsBrisbane Angels
Q-Sera is a biotech company backed by Australian investors Uniseed and Brandon BioCatalyst, emerging from University of Queensland commercialisation efforts.
BiotechHealthtechMedical DevicesBrisbane, AU
Michael Grant(Chief Executive Officer)in
Co-investorsBrandon BioCatalystUniSeed Pty Ltd.
QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy.
BiotechFemTechHealthtechMedical DevicesAtlanta, US
Co-investorsBrandon BioCatalyst
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BioScoutCardihabForciteKinoxisLenexaNexgenplantsQUE Oncology
Portfolio news
latest coverage across their companiesUniseed · smartcompany.com.au · Apr 17, 2026
Ferronova · ferronova.com.au · Dec 17, 2025
Morse Micro · computerweekly.com · Sep 23, 2025
PERKii · uniquest.com.au · May 25, 2025
Frequently asked questions
- How many investments has Stoic VC made?
- Stoic VC has 25 tracked investments.
- What stage does Stoic VC invest at?
- Stoic VC invests at the Pre-Seed, Seed, Series A stages.
- What is Stoic VC's typical check size?
- Stoic VC typically writes checks of $65K – $650K.
- What sectors does Stoic VC focus on?
- Stoic VC focuses on AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Healthtech, Medical Devices.
- Where is Stoic VC located?
- Stoic VC is headquartered in Sydney, AU.
- Does Stoic VC lead rounds?
- Stoic VC typically participates in rounds rather than leading them.
- Who does Stoic VC co-invest with?
- Stoic VC most often shares deals with Brandon BioCatalyst, Artesian, Blackbird Ventures, among 15 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Innovobot is an investment and innovation platform focused on deep tech, combining a venture fund (IRV), an innovation studio (Innovobot Labs), and engineering services to foster technologies that address social, industrial and environmental challenges.